"Choosing a Drug to Prevent Malaria". Centers for Disease Control and Prevention. February 2023. Doxycycline. Archived from the original on 13 November 2016. Retrieved 4 December 2023.
Stoddard RA, Galloway RL, Guerra MA (10 July 2015). "Leptospirosis". Yellow Book. Atlanta, GA: Centers for Disease Control and Prevention. Archived from the original on 9 April 2017. Retrieved 16 April 2017.
Sweet RL, Schachter J, Landers DV, Ohm-Smith M, Robbie MO (March 1988). "Treatment of hospitalized patients with acute pelvic inflammatory disease: comparison of cefotetan plus doxycycline and cefoxitin plus doxycycline". American Journal of Obstetrics and Gynecology. 158 (3 Pt 2): 736–41. doi:10.1016/S0002-9378(16)44537-0. PMID3162653.
Gjønnaess H, Holten E (1978). "Doxycycline (Vibramycin) in pelvic inflammatory disease". Acta Obstetricia et Gynecologica Scandinavica. 57 (2): 137–9. doi:10.3109/00016347809155893. PMID345730. S2CID28328073.
Holmes NE, Charles PG (5 January 2009). "Safety and Efficacy Review of Doxycycline". Clinical Medicine. Therapeutics. 1: CMT.S2035. doi:10.4137/CMT.S2035. S2CID58790579.
Määttä M, Kari O, Tervahartiala T, Peltonen S, Kari M, Saari M, et al. (August 2006). "Tear fluid levels of MMP-8 are elevated in ocular rosacea--treatment effect of oral doxycycline". Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv für Klinische und Experimentelle Ophthalmologie. 244 (8): 957–62. doi:10.1007/s00417-005-0212-3. PMID16411105. S2CID20540747.
Quarterman MJ, Johnson DW, Abele DC, Lesher JL, Hull DS, Davis LS (January 1997). "Ocular rosacea. Signs, symptoms, and tear studies before and after treatment with doxycycline". Archives of Dermatology. 133 (1): 49–54. doi:10.1001/archderm.133.1.49. PMID9006372.
Walker DH, Paddock CD, Dumler JS (November 2008). "Emerging and re-emerging tick-transmitted rickettsial and ehrlichial infections". The Medical Clinics of North America. 92 (6): 1345–61, x. doi:10.1016/j.mcna.2008.06.002. PMID19061755.
Nadelman RB, Luger SW, Frank E, Wisniewski M, Collins JJ, Wormser GP (August 1992). "Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease". Annals of Internal Medicine. 117 (4): 273–80. doi:10.7326/0003-4819-117-4-273. PMID1637021. S2CID23358315.
Karlsson M, Hammers-Berggren S, Lindquist L, Stiernstedt G, Svenungsson B (July 1994). "Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis". Neurology. 44 (7): 1203–7. doi:10.1212/WNL.44.7.1203. PMID8035916. S2CID38661885.
Karlsson U, Bjöersdorff A, Massung RF, Christensson B (2001). "Human granulocytic ehrlichiosis--a clinical case in Scandinavia". Scandinavian Journal of Infectious Diseases. 33 (1): 73–4. doi:10.1080/003655401750064130. PMID11234985. S2CID218880245.
Okada T, Morozumi M, Tajima T, Hasegawa M, Sakata H, Ohnari S, et al. (December 2012). "Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children". Clinical Infectious Diseases. 55 (12): 1642–9. doi:10.1093/cid/cis784. PMID22972867.
Taylor-Salmon E, Shapiro ED (April 2024). "Tick-borne infections in children in North America". Curr Opin Pediatr. 36 (2): 156–163. doi:10.1097/MOP.0000000000001326. PMC 10932821. PMID38167816.
Roca Mora MM, Cunha LM, Godoi A, Donadon I, Clemente M, Marcolin P, et al. (June 2024). "Shorter versus longer duration of antimicrobial therapy for early Lyme disease: A systematic review and meta-analysis". Diagn Microbiol Infect Dis. 109 (2): 116215. doi:10.1016/j.diagmicrobio.2024.116215. PMID38493509.
Dreno B, Thiboutot D, Gollnick H, Bettoli V, Kang S, Leyden JJ, et al. (2014). "Antibiotic stewardship in dermatology: limiting antibiotic use in acne". European Journal of Dermatology. 24 (3): 330–4. doi:10.1684/ejd.2014.2309. PMID24721547. S2CID28700961.
Sgolastra F, Petrucci A, Gatto R, Giannoni M, Monaco A (November 2011). "Long-term efficacy of subantimicrobial-dose doxycycline as an adjunctive treatment to scaling and root planing: a systematic review and meta-analysis". Journal of Periodontology. 82 (11): 1570–1581. doi:10.1902/jop.2011.110026. PMID21417590.
Hoerauf A, Mand S, Fischer K, Kruppa T, Marfo-Debrekyei Y, Debrah AY, et al. (November 2003). "Doxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production". Medical Microbiology and Immunology. 192 (4): 211–6. doi:10.1007/s00430-002-0174-6. PMID12684759. S2CID23349595.
Taylor MJ, Makunde WH, McGarry HF, Turner JD, Mand S, Hoerauf A (2005). "Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomised placebo-controlled trial". Lancet. 365 (9477): 2116–21. doi:10.1016/S0140-6736(05)66591-9. PMID15964448. S2CID21382828.
Mylonas I (January 2011). "Antibiotic chemotherapy during pregnancy and lactation period: aspects for consideration". Archives of Gynecology and Obstetrics. 283 (1): 7–18. doi:10.1007/s00404-010-1646-3. PMID20814687. S2CID25492353.
Lee TW, Russell L, Deng M, Gibson PR (August 2013). "Association of doxycycline use with the development of gastroenteritis, irritable bowel syndrome and inflammatory bowel disease in Australians deployed abroad". Internal Medicine Journal. 43 (8): 919–26. doi:10.1111/imj.12179. PMID23656210. S2CID9418654.
Margolis DJ, Fanelli M, Hoffstad O, Lewis JD (December 2010). "Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease". The American Journal of Gastroenterology. 105 (12): 2610–6. doi:10.1038/ajg.2010.303. PMID20700115. S2CID20085592.
Archer JS, Archer DF (June 2002). "Oral contraceptive efficacy and antibiotic interaction: a myth debunked". Journal of the American Academy of Dermatology. 46 (6): 917–23. doi:10.1067/mjd.2002.120448. PMID12063491.
Leung E, Landa G (September 2013). "Update on current and future novel therapies for dry age-related macular degeneration". Expert Review of Clinical Pharmacology. 6 (5): 565–79. doi:10.1586/17512433.2013.829645. PMID23971874. S2CID26680094.
Greenwald RA (December 2011). "The road forward: the scientific basis for tetracycline treatment of arthritic disorders". Pharmacological Research. 64 (6): 610–3. doi:10.1016/j.phrs.2011.06.010. PMID21723947.
Henehan M, Montuno M, De Benedetto A (November 2017). "Doxycycline as an anti-inflammatory agent: updates in dermatology". Journal of the European Academy of Dermatology and Venereology. 31 (11): 1800–1808. doi:10.1111/jdv.14345. PMID28516469. S2CID37723341.
Berman B, Perez OA, Zell D (January 2007). "Update on rosacea and anti-inflammatory-dose doxycycline". Drugs of Today. 43 (1): 27–34. doi:10.1358/dot.2007.43.1.1025697. PMID17315050.
Lagente V, Victoni T, Boichot E (2011). "Matrix Metalloproteinase Inhibitors as New Anti-inflammatory Drugs". Proteases and Their Receptors in Inflammation. Progress in Inflammation Research. Springer. pp. 101–122. doi:10.1007/978-3-0348-0157-7_5. ISBN978-3-0348-0156-0.
Mello BSF, Chaves Filho AJM, Custódio CS, Rodrigues PA, Carletti JV, Vasconcelos SMM, et al. (September 2021). "Doxycycline at subantimicrobial dose combined with escitalopram reverses depressive-like behavior and neuroinflammatory hippocampal alterations in the lipopolysaccharide model of depression". J Affect Disord. 292: 733–745. doi:10.1016/j.jad.2021.05.083. PMID34161892.
do Amaral L, Dos Santos NAG, Sisti FM, Del Bel E, Dos Santos AC (August 2023). "Doxycycline inhibits dopaminergic neurodegeneration through upregulation of axonal and synaptic proteins". Naunyn-Schmiedeberg's Arch Pharmacol. 396 (8): 1787–1796. doi:10.1007/s00210-023-02435-3. PMID36843128. S2CID257218181.
Leyder E, Suresh P, Jun R, Overbey K, Banerjee T, Melnikova T, et al. (February 2023). "Depression-related phenotypes at early stages of Aβ and tau accumulation in inducible Alzheimer's disease mouse model: Task-oriented and concept-driven interpretations". Behav Brain Res. 438: 114187. doi:10.1016/j.bbr.2022.114187. PMID36343696. S2CID253300844.
Dursun D, Kim MC, Solomon A, Pflugfelder SC (July 2001). "Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline and corticosteroids". American Journal of Ophthalmology. 132 (1): 8–13. doi:10.1016/S0002-9394(01)00913-8. PMID11438047.
drugbank.ca
"Doxycycline". www.drugbank.ca. Archived from the original on 10 November 2008. Retrieved 23 January 2019.
drugs.com
"Doxycycline calcium". The American Society of Health-System Pharmacists. Archived from the original on 23 September 2015. Retrieved 18 August 2015.
World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
Sweet RL, Schachter J, Landers DV, Ohm-Smith M, Robbie MO (March 1988). "Treatment of hospitalized patients with acute pelvic inflammatory disease: comparison of cefotetan plus doxycycline and cefoxitin plus doxycycline". American Journal of Obstetrics and Gynecology. 158 (3 Pt 2): 736–41. doi:10.1016/S0002-9378(16)44537-0. PMID3162653.
Gjønnaess H, Holten E (1978). "Doxycycline (Vibramycin) in pelvic inflammatory disease". Acta Obstetricia et Gynecologica Scandinavica. 57 (2): 137–9. doi:10.3109/00016347809155893. PMID345730. S2CID28328073.
Määttä M, Kari O, Tervahartiala T, Peltonen S, Kari M, Saari M, et al. (August 2006). "Tear fluid levels of MMP-8 are elevated in ocular rosacea--treatment effect of oral doxycycline". Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv für Klinische und Experimentelle Ophthalmologie. 244 (8): 957–62. doi:10.1007/s00417-005-0212-3. PMID16411105. S2CID20540747.
Quarterman MJ, Johnson DW, Abele DC, Lesher JL, Hull DS, Davis LS (January 1997). "Ocular rosacea. Signs, symptoms, and tear studies before and after treatment with doxycycline". Archives of Dermatology. 133 (1): 49–54. doi:10.1001/archderm.133.1.49. PMID9006372.
Walker DH, Paddock CD, Dumler JS (November 2008). "Emerging and re-emerging tick-transmitted rickettsial and ehrlichial infections". The Medical Clinics of North America. 92 (6): 1345–61, x. doi:10.1016/j.mcna.2008.06.002. PMID19061755.
Nadelman RB, Luger SW, Frank E, Wisniewski M, Collins JJ, Wormser GP (August 1992). "Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease". Annals of Internal Medicine. 117 (4): 273–80. doi:10.7326/0003-4819-117-4-273. PMID1637021. S2CID23358315.
Karlsson M, Hammers-Berggren S, Lindquist L, Stiernstedt G, Svenungsson B (July 1994). "Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis". Neurology. 44 (7): 1203–7. doi:10.1212/WNL.44.7.1203. PMID8035916. S2CID38661885.
Weinstein RS (November 1996). "Human ehrlichiosis". American Family Physician. 54 (6): 1971–6. PMID8900357.
Karlsson U, Bjöersdorff A, Massung RF, Christensson B (2001). "Human granulocytic ehrlichiosis--a clinical case in Scandinavia". Scandinavian Journal of Infectious Diseases. 33 (1): 73–4. doi:10.1080/003655401750064130. PMID11234985. S2CID218880245.
Okada T, Morozumi M, Tajima T, Hasegawa M, Sakata H, Ohnari S, et al. (December 2012). "Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children". Clinical Infectious Diseases. 55 (12): 1642–9. doi:10.1093/cid/cis784. PMID22972867.
Taylor-Salmon E, Shapiro ED (April 2024). "Tick-borne infections in children in North America". Curr Opin Pediatr. 36 (2): 156–163. doi:10.1097/MOP.0000000000001326. PMC 10932821. PMID38167816.
Roca Mora MM, Cunha LM, Godoi A, Donadon I, Clemente M, Marcolin P, et al. (June 2024). "Shorter versus longer duration of antimicrobial therapy for early Lyme disease: A systematic review and meta-analysis". Diagn Microbiol Infect Dis. 109 (2): 116215. doi:10.1016/j.diagmicrobio.2024.116215. PMID38493509.
Dreno B, Thiboutot D, Gollnick H, Bettoli V, Kang S, Leyden JJ, et al. (2014). "Antibiotic stewardship in dermatology: limiting antibiotic use in acne". European Journal of Dermatology. 24 (3): 330–4. doi:10.1684/ejd.2014.2309. PMID24721547. S2CID28700961.
Sgolastra F, Petrucci A, Gatto R, Giannoni M, Monaco A (November 2011). "Long-term efficacy of subantimicrobial-dose doxycycline as an adjunctive treatment to scaling and root planing: a systematic review and meta-analysis". Journal of Periodontology. 82 (11): 1570–1581. doi:10.1902/jop.2011.110026. PMID21417590.
Hoerauf A, Mand S, Fischer K, Kruppa T, Marfo-Debrekyei Y, Debrah AY, et al. (November 2003). "Doxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production". Medical Microbiology and Immunology. 192 (4): 211–6. doi:10.1007/s00430-002-0174-6. PMID12684759. S2CID23349595.
Taylor MJ, Makunde WH, McGarry HF, Turner JD, Mand S, Hoerauf A (2005). "Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomised placebo-controlled trial". Lancet. 365 (9477): 2116–21. doi:10.1016/S0140-6736(05)66591-9. PMID15964448. S2CID21382828.
Mylonas I (January 2011). "Antibiotic chemotherapy during pregnancy and lactation period: aspects for consideration". Archives of Gynecology and Obstetrics. 283 (1): 7–18. doi:10.1007/s00404-010-1646-3. PMID20814687. S2CID25492353.
Lee TW, Russell L, Deng M, Gibson PR (August 2013). "Association of doxycycline use with the development of gastroenteritis, irritable bowel syndrome and inflammatory bowel disease in Australians deployed abroad". Internal Medicine Journal. 43 (8): 919–26. doi:10.1111/imj.12179. PMID23656210. S2CID9418654.
Margolis DJ, Fanelli M, Hoffstad O, Lewis JD (December 2010). "Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease". The American Journal of Gastroenterology. 105 (12): 2610–6. doi:10.1038/ajg.2010.303. PMID20700115. S2CID20085592.
Archer JS, Archer DF (June 2002). "Oral contraceptive efficacy and antibiotic interaction: a myth debunked". Journal of the American Academy of Dermatology. 46 (6): 917–23. doi:10.1067/mjd.2002.120448. PMID12063491.
Leung E, Landa G (September 2013). "Update on current and future novel therapies for dry age-related macular degeneration". Expert Review of Clinical Pharmacology. 6 (5): 565–79. doi:10.1586/17512433.2013.829645. PMID23971874. S2CID26680094.
Greenwald RA (December 2011). "The road forward: the scientific basis for tetracycline treatment of arthritic disorders". Pharmacological Research. 64 (6): 610–3. doi:10.1016/j.phrs.2011.06.010. PMID21723947.
Henehan M, Montuno M, De Benedetto A (November 2017). "Doxycycline as an anti-inflammatory agent: updates in dermatology". Journal of the European Academy of Dermatology and Venereology. 31 (11): 1800–1808. doi:10.1111/jdv.14345. PMID28516469. S2CID37723341.
Berman B, Perez OA, Zell D (January 2007). "Update on rosacea and anti-inflammatory-dose doxycycline". Drugs of Today. 43 (1): 27–34. doi:10.1358/dot.2007.43.1.1025697. PMID17315050.
Mello BSF, Chaves Filho AJM, Custódio CS, Rodrigues PA, Carletti JV, Vasconcelos SMM, et al. (September 2021). "Doxycycline at subantimicrobial dose combined with escitalopram reverses depressive-like behavior and neuroinflammatory hippocampal alterations in the lipopolysaccharide model of depression". J Affect Disord. 292: 733–745. doi:10.1016/j.jad.2021.05.083. PMID34161892.
do Amaral L, Dos Santos NAG, Sisti FM, Del Bel E, Dos Santos AC (August 2023). "Doxycycline inhibits dopaminergic neurodegeneration through upregulation of axonal and synaptic proteins". Naunyn-Schmiedeberg's Arch Pharmacol. 396 (8): 1787–1796. doi:10.1007/s00210-023-02435-3. PMID36843128. S2CID257218181.
Leyder E, Suresh P, Jun R, Overbey K, Banerjee T, Melnikova T, et al. (February 2023). "Depression-related phenotypes at early stages of Aβ and tau accumulation in inducible Alzheimer's disease mouse model: Task-oriented and concept-driven interpretations". Behav Brain Res. 438: 114187. doi:10.1016/j.bbr.2022.114187. PMID36343696. S2CID253300844.
Dursun D, Kim MC, Solomon A, Pflugfelder SC (July 2001). "Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline and corticosteroids". American Journal of Ophthalmology. 132 (1): 8–13. doi:10.1016/S0002-9394(01)00913-8. PMID11438047.
Gjønnaess H, Holten E (1978). "Doxycycline (Vibramycin) in pelvic inflammatory disease". Acta Obstetricia et Gynecologica Scandinavica. 57 (2): 137–9. doi:10.3109/00016347809155893. PMID345730. S2CID28328073.
Holmes NE, Charles PG (5 January 2009). "Safety and Efficacy Review of Doxycycline". Clinical Medicine. Therapeutics. 1: CMT.S2035. doi:10.4137/CMT.S2035. S2CID58790579.
Määttä M, Kari O, Tervahartiala T, Peltonen S, Kari M, Saari M, et al. (August 2006). "Tear fluid levels of MMP-8 are elevated in ocular rosacea--treatment effect of oral doxycycline". Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv für Klinische und Experimentelle Ophthalmologie. 244 (8): 957–62. doi:10.1007/s00417-005-0212-3. PMID16411105. S2CID20540747.
Nadelman RB, Luger SW, Frank E, Wisniewski M, Collins JJ, Wormser GP (August 1992). "Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease". Annals of Internal Medicine. 117 (4): 273–80. doi:10.7326/0003-4819-117-4-273. PMID1637021. S2CID23358315.
Karlsson M, Hammers-Berggren S, Lindquist L, Stiernstedt G, Svenungsson B (July 1994). "Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis". Neurology. 44 (7): 1203–7. doi:10.1212/WNL.44.7.1203. PMID8035916. S2CID38661885.
Karlsson U, Bjöersdorff A, Massung RF, Christensson B (2001). "Human granulocytic ehrlichiosis--a clinical case in Scandinavia". Scandinavian Journal of Infectious Diseases. 33 (1): 73–4. doi:10.1080/003655401750064130. PMID11234985. S2CID218880245.
Dreno B, Thiboutot D, Gollnick H, Bettoli V, Kang S, Leyden JJ, et al. (2014). "Antibiotic stewardship in dermatology: limiting antibiotic use in acne". European Journal of Dermatology. 24 (3): 330–4. doi:10.1684/ejd.2014.2309. PMID24721547. S2CID28700961.
Hoerauf A, Mand S, Fischer K, Kruppa T, Marfo-Debrekyei Y, Debrah AY, et al. (November 2003). "Doxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production". Medical Microbiology and Immunology. 192 (4): 211–6. doi:10.1007/s00430-002-0174-6. PMID12684759. S2CID23349595.
Taylor MJ, Makunde WH, McGarry HF, Turner JD, Mand S, Hoerauf A (2005). "Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomised placebo-controlled trial". Lancet. 365 (9477): 2116–21. doi:10.1016/S0140-6736(05)66591-9. PMID15964448. S2CID21382828.
Mylonas I (January 2011). "Antibiotic chemotherapy during pregnancy and lactation period: aspects for consideration". Archives of Gynecology and Obstetrics. 283 (1): 7–18. doi:10.1007/s00404-010-1646-3. PMID20814687. S2CID25492353.
Lee TW, Russell L, Deng M, Gibson PR (August 2013). "Association of doxycycline use with the development of gastroenteritis, irritable bowel syndrome and inflammatory bowel disease in Australians deployed abroad". Internal Medicine Journal. 43 (8): 919–26. doi:10.1111/imj.12179. PMID23656210. S2CID9418654.
Margolis DJ, Fanelli M, Hoffstad O, Lewis JD (December 2010). "Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease". The American Journal of Gastroenterology. 105 (12): 2610–6. doi:10.1038/ajg.2010.303. PMID20700115. S2CID20085592.
Leung E, Landa G (September 2013). "Update on current and future novel therapies for dry age-related macular degeneration". Expert Review of Clinical Pharmacology. 6 (5): 565–79. doi:10.1586/17512433.2013.829645. PMID23971874. S2CID26680094.
Henehan M, Montuno M, De Benedetto A (November 2017). "Doxycycline as an anti-inflammatory agent: updates in dermatology". Journal of the European Academy of Dermatology and Venereology. 31 (11): 1800–1808. doi:10.1111/jdv.14345. PMID28516469. S2CID37723341.
do Amaral L, Dos Santos NAG, Sisti FM, Del Bel E, Dos Santos AC (August 2023). "Doxycycline inhibits dopaminergic neurodegeneration through upregulation of axonal and synaptic proteins". Naunyn-Schmiedeberg's Arch Pharmacol. 396 (8): 1787–1796. doi:10.1007/s00210-023-02435-3. PMID36843128. S2CID257218181.
Leyder E, Suresh P, Jun R, Overbey K, Banerjee T, Melnikova T, et al. (February 2023). "Depression-related phenotypes at early stages of Aβ and tau accumulation in inducible Alzheimer's disease mouse model: Task-oriented and concept-driven interpretations". Behav Brain Res. 438: 114187. doi:10.1016/j.bbr.2022.114187. PMID36343696. S2CID253300844.
"Doxycycline calcium". The American Society of Health-System Pharmacists. Archived from the original on 23 September 2015. Retrieved 18 August 2015.
"Malaria". Fit for Travel. Public Health Scotland. Chemoprophylaxis. Archived from the original on 4 December 2023. Retrieved 4 December 2023.
"Choosing a Drug to Prevent Malaria". Centers for Disease Control and Prevention. February 2023. Doxycycline. Archived from the original on 13 November 2016. Retrieved 4 December 2023.
Stoddard RA, Galloway RL, Guerra MA (10 July 2015). "Leptospirosis". Yellow Book. Atlanta, GA: Centers for Disease Control and Prevention. Archived from the original on 9 April 2017. Retrieved 16 April 2017.